COVID-19 Research Paper Volume 13, Issue 8 pp 10833—10852

Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19

class="figure-viewer-img"

Figure 2. Risk of bias graph.